Return to homepagePandemic Pact

CompLS - Round 4 - Collaborative project: CAP-TSD - Causal analysis and predictive modelling of molecular and clinical time series data of pneumonia patients - Subproject B

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:4 publications

Grant number: 031L0286B

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2025

  • Known Financial Commitments (USD)

    $519,534.52

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Principal Investigator

    N/A

  • Research Location

    Germany

  • Lead Research Institution

    Charité - Universitätsmedizin Berlin

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

4 Publications linked via Europe PMC

Last Updated:6 days ago

View all publications at Europe PMC

Plasma Proteomics Reveals Distinct Signatures in Occult and Microfilaremic Loa loa Infections.

Comparative Analysis of Initial Full Blood Count Parameters in Adults Infected With Plasmodium falciparum for Classification of Disease Severity and Previous Exposure Across Endemic (Gabon) and Nonendemic (Germany) Settings.

Biomarkers troponin and procalcitonin in addition to CRB-65 enhance risk stratification in patients with community-acquired pneumonia.

The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation.